DOMAIN Therapeutics is a company that is committed to improving patients’ life by delivering innovative cancer immunotherapies and treatments for neurologic disorders and rare diseases.
The company aims to make an impactful difference for patients who suffer from cancer by discovering treatments that address GPCR -mediated immunosuppression.
The company develops a robust pipeline in immune-oncology and progresses its advanced programs towards the clinic, using its expertise, innovative approach and proprietary platform.
The company has also built a pipeline of GPCR-based programs in neurology and rare diseases over the past decade. Domain is developing by establishing early partnerships on its neurology and rare disease assets..